Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of two vismodegib regimens in patients with multiple basal cell carcinomas
NL-OMON43727Phase 2Active, not recruiting
- Sponsor
- Roche
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vismodegib, sponsored by Roche. Started Oct 2013; status: active, not recruiting.
02
Drugs
vismodegib
Beyond the preview
Go deeper on NL-OMON43727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43727.